Suscribirse

Intramuscular psoas lengthening during single-event multi-level surgery fails to improve hip dynamics in children with spastic diplegia. Clinical and kinematic outcomes in the short- and medium-terms - 09/05/16

Doi : 10.1016/j.otsr.2016.01.022 
C. Mallet , A.-L. Simon, B. Ilharreborde, A. Presedo, K. Mazda, G.-F. Penneçot
 Service de Chirurgie Orthopédique Pédiatrique, CHU Robert-Debré, Université Paris-Diderot, 48, boulevard Sérurier, 75019 Paris, France 

Corresponding author. Tel.: +33 1 40 03 20 34.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

In children with spastic diplegia, hip extension in terminal stance is limited by retraction of the psoas muscle, which decreases stride propulsion and step length on the contralateral side. Whether intramuscular psoas lengthening (IMPL) is effective remains controversial. The objective of this study was to assess the impact of IMPL as a component of single-event multi-level surgery (SEMLS) on spatial and temporal gait parameters, clinical hip flexion deformity, and hip flexion kinematics.

Hypothesis

IMPL as part of SEMLS does not significantly improve hip flexion kinematics.

Materials and methods

A retrospective review was conducted of the medical charts of consecutive ambulatory children with cerebral palsy who had clinical hip flexion deformity (>10°) with more than 10° of excess hip flexion in terminal stance and who underwent SEMLS. The groups with and without IMPL were compared. Preoperative values of the clinical hip flexion contracture, hip flexion kinematics in terminal stance, and spatial and temporal gait parameters were compared to the values recorded after a mean postoperative follow-up of 2.4±2.0 years (range, 1.0–8.7 years). Follow-up was longer than 3 years in 6 patients.

Results

Of 47 lower limbs (in 34 patients) included in the analysis, 15 were managed with IMPL. There were no significant between-group differences at baseline. Surgery was followed in all limbs by significant decreases in kinematic hip flexion and in the Gillette Gait Index. In the IMPL group, significant improvements occurred in clinical hip flexion deformity, walking speed, and step length. The improvement in kinematic hip extension was not significantly different between the two groups. Crouch gait recurred in 3 (8%) patients.

Discussion

The improvement in kinematic hip extension in terminal stance was not significantly influenced by IMPL but was, instead, chiefly dependent on improved knee extension and on the position of the ground reaction vector after SEMLS. IMPL remains indicated only when the clinical hip flexion deformity exceeds 20°.

Level of evidence

IV, retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Psoas lengthening, Hip flexor contracture, Cerebral palsy, Quantitative gait analysis


Esquema


© 2016  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 102 - N° 4

P. 501-506 - juin 2016 Regresar al número
Artículo precedente Artículo precedente
  • Flexibility analysis in adolescent idiopathic scoliosis on side-bending images using the EOS imaging system
  • C. Hirsch, B. Ilharreborde, K. Mazda
| Artículo siguiente Artículo siguiente
  • Outpatient Latarjet surgery for gleno-humeral instability: Prospective comparative assessment of feasibility and safety
  • Y. Bohu, S. Klouche, A. Gerometta, S. Herman, N. Lefevre

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.